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The reason for investigating NCX3 as a possible target for SUMO-mediated neuroprotective effect is that NCX3 plays a relevant neuroprotective role in cerebral ischemia. 16, 17 Indeed, both NCX3 knockdown and NCX3 knockout exacerbate ischemic damage induced by permanent and transient middle cerebral artery occlusion (tMCAO). 16, 17 More intriguingly, NCX3 is a new additional effector of ischemic preconditioning. 18 Given these premises, the aim of this study was to evaluate whether NCX3 is a target for sumoylation and whether this posttranslational modification participates in promoting ischemic preconditioning-induced neuroprotection. For these aims, we analyzed (1) SUMO1 conjugation pattern after ischemic preconditioning, (2) the effect of SUMO1 knockdown on ischemic damage after tMCAO and ischemic preconditioning, (3) the possible interaction between SUMO1 and NCX3, and finally, (4) the molecular determinants of NCX3 sequence responsible for sumoylation.
Methods
Experimental Groups
Male Sprague-Dawley rats (n=110; 250-300 g; Charles River) were housed under diurnal lighting conditions (12 hours darkness/light). Experiments were performed according to the international guidelines for animal research and approved by the Animal Care Committee of "Federico II" University of Naples (Naples, Italy).
Focal Ischemia
Transient focal ischemia was induced, as previously described, 19, 20 by suture occlusion of the right middle cerebral artery in male rats anesthetized with 1.5% sevoflurane, 70% N 2 O, and 28.5% O 2 . Achievement of ischemia was confirmed by monitoring regional cerebral blood flow in the area of the right middle cerebral artery through a laser Doppler (PF5001; Perimed, Sweden). 19 Animals not showing a cerebral blood flow reduction of at least 70% (n=8), as well as those dying after ischemia induction (n=5), were excluded from the study. Rectal temperature was maintained at 37±0.5°C with a thermostatically controlled heating pad and lamp. After 100 minutes middle cerebral artery occlusion, rats were reanesthetized and the filament was withdrawn to restore blood flow. Animals were randomized into the different experimental groups, containing each one 5 to 8 animals, in a blind manner. Sham-operated animals subjected to the entire surgical procedure for tMCAO induction except for the insertion of the filament.
Ischemic Preconditioning
Ischemic preconditioning was induced a by subjecting rats to 30 minutes of MCAO, followed by 72 hours of reperfusion. 18 At the end of the reperfusion period, the middle cerebral artery was reoccluded for 100 minutes. Cerebral blood flow reduction was 80.4±1.4 in tMCAO group, 81.2±1.6 in preconditioning group, and 82.5±2.5 in preconditioning+tMCAO group.
Evaluation of the Infarct Volume
For the analysis of ischemic damage, rats were euthanized 24 or 72 hours after tMCAO or preconditioning+tMCAO. The ischemic volume was evaluated with 2,3,5-triphenyl tetrazolium chloride staining and calculated with image analysis software (Image-ProPlus). 21 The total infarct volume was expressed as percentage of the volume of the hemisphere ipsilateral to the lesion to correct brain edema and evaluated in a blind manner.
Intracerebroventricular Administration of siRNA
In rats positioned on a stereotaxic frame, a 23-g stainless steel guide cannula was implanted into the right lateral ventricle using the stereotaxic coordinates from the bregma: 0.4 mm caudal, 2 mm lateral, and 2 mm below the dura. 16, 22 Two different siRNAs were tested (Quiagen siRNA-A #SI01910034 and siRNA-B #SI01910027). siRNAs (10 μL, 2 μM or 10 μM) and siCTL were intracerebroventricularly administered twice a day for 3 days. Because their effectiveness was similar (≈50% reduction), all the experiments were performed with siRNA-A (10 μL, 10 μM). In preconditioning+tMCAO group, siRNA was administered twice a day every 12 hours for 3 days, starting 72 hours before preconditioning stimulus induction. By contrast, in the MCAO groups, siRNA was administered twice a day, at intervals of 12 hours, starting 72 hours before tMCAO induction until the day before the euthanization.
Western Blotting Analysis
Cortical samples were harvested from ischemic brains of rats subjected to tMCAO, preconditioning, and preconditioning+tMCAO. Ipsilateral cortex and striatum were obtained at 4 different reperfusion time intervals after the last occlusion, ie, at 3, 5, 24, and 72 hours. To limit the number of control groups, the same samples were obtained from brains of control untouched animals. To justify the use of untouched animals as controls, we performed immunohistochemical analysis, which revealed no differences in SUMO1 and NCX3 signals between the temporoparietal cortex of untouched animals and the contralateral temporoparietal cortex of animals subjected to tMCAO, preconditioning, and preconditioning+tMCAO ( Figure I in the online-only Data Supplement).
Blots were probed with SUMO1 antibody (rabbit polyclonal, dilution 1:1000; kindly given by Hallenbeck J.M. from National Institute of Neurological Disorders and Stroke and NIH, Bethesda, MD), or with NCX3 antibody (rabbit polyclonal, dilution 1:1000; kindly given by Philipson K. from David Geffen School of Medicine at UCLA, Los Angeles, CA) overnight at 4°C. Finally, detection was achieved using a horseradish peroxidase-conjugated secondary anti-rabbit antibody (1:2000; Cell Signaling) and an enhanced luminescence kit (GE Healthcare, Milan, Italy). 23 As already reported, the blots showed the typical band of SUMOylated RanGAP1 at ≈100 kDa and a ladder of protein bands of SUMO1 conjugates. 24 For the analysis of the sumoylation pattern, the region corresponding to molecular weights 40 to 260 kDa in each lane was cropped, the total intensity was analyzed, 11, 25 and the densitometry values were expressed as percentage of the control animals. The same blots were then reprobed with β-actin antibody (mouse monoclonal, dilution 1:1000, Sigma-Aldrich, Milan, Italy) as an internal control.
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Generation and Stable Expression of WildType and Mutant NCX3 FLAG cDNAs
Murine NCX3 cDNA with a 3XFLAG epitope at the C-terminus (NCX3 FLAG ) was cloned in pReceiver-M13 expressing vector by Genecopoeia. Site-directed and deletion mutants of NCX3 FLAG were generated by means of QuikChange strategy (Stratagene, La Jolla, CA). In particular, the amino acid regions 292 to 710 and 528 to 676 were deleted from NCX3 FLAG obtaining a mutant lacking the entire f-loop, NCX3∆292 to 710 (NCX3∆f), and another lacking a portion of f-loop, NCX3∆528 to 676, respectively. Two site-directed mutants were obtained by substituting lysine456 with glutamate (NCX3K456E), and phenylalanine 589 and lysine 590 with leucine and glutamate, respectively (NCX3FK589LE).
All mutant exchangers obtained were verified by sequencing both DNA strands (Primm, Milan, Italy 
Immunoprecipitation Assay
BHK cells expressing NCX3 wild-type and mutant forms and brain cortex from control rats and rats exposed to tMCAO or preconditioning followed by tMCAO were homogenized in lysis buffer containing: 50 mmol/L Hepes, pH, 7.4; 100 mmol/L NaCl; 1.5 mmol/L MgCl 2 ; 0.2% nonyl phenoxypolyethoxylethanol (NP40) with protease inhibitor cocktail; 1 mmol/L phenylmethanesulfonyl fluoride (PMSF); and 20 mmol/L N-ethylmaleimide (NEM). One milligram of lysate was precleared using protein A/Gplus (Santa Cruz, Dallas, TX) for 1 hour at 4°C with constant rotation and centrifuged for 2 minutes at 8000 rpm. Precleared lysates from BHK cells were immunoprecipitated with anti-SUMO1 antibody (1:100; monoclonal anti-SUMO1 antibody, Quiagen) and resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to a nitrocellulose membrane. Immunoblot analysis was performed using an antiflag antibody. Regarding lysates from brain tissue, 1 mg of precleared lysate was immunoprecipitated with an anti-NCX3 antibody (1:100 polyclonal anti-NCX3 antibody, Swant) using the same experimental procedure described above. Finally, total lysates or immunoprecipitates were resolved by SDS-PAGE gel and transferred to a nitrocellulose membrane. Immunoblot analysis was performed using anti-SUMO1 and anti-NCX3 antibodies.
Primary Cortical Neurons and Immunocytochemistry
Mixed cultures of cortical neurons from 2-to 4-day old Wistar rat pups were prepared as previously described. 28, 29 For the immunocytochemistry experiments, cortical neurons were rinsed twice in cold 0.01 mol/L phosphate-buffered saline at pH 7.4 and fixed at room temperature in 4%(wt/vol) paraformaldehyde (SigmaAldrich) for 20 minutes. Cells were blocked in phosphate-buffered saline containing 10% fetal bovine serum and the following antibodies: anti-NCX3 rabbit (kindly supplied by Dr. Philipson, dilution 1:4000) and anti-SUMO monoclonal mouse (dilution 1:1000, Santa Cruz). Neurons were then incubated overnight at 4°C. Next, slides were washed in phosphate-buffered saline, incubated with anti-rabbit cy2 antibody (dilution 1:200, Jackson Immunoresearch Laboratories), and anti-mouse cy3 antibody (dilution 1:200, Jackson Immunoresearch Laboratories) for 1 hour at room temperature (25°C) under dark conditions, and washed again with phosphatebuffered saline. Finally, they were mounted onto Slow fade antifade (Invitrogen-Molecular Probes) and images were observed using a Zeiss LSM700 META/laser scanning confocal microscope. Single images were taken with an optical thickness of 0.7 μm with a size of 1024×1024 pixels.
Tissue Processing, Immunostaining, and Confocal Immunofluorescence
For the histological examination, control untouched animals or animals exposed to tMCAO, preconditioning, or preconditioning+tMCAO were transcardially perfused under deep anesthesia with saline solution containing 0.01 mL heparin, followed by 60 mL of 4% paraformaldehyde in saline solution. The brains were removed and postfixed 
Statistic Analysis
Values are expressed as means±SEM. Statistical analysis was performed with 2-way ANOVA, followed by Newman-Keuls test. Statistical significance was accepted at the 95% confidence level (P<0.05).
Results
SUMO1 Conjugation Increases in the Temporoparietal Cortex After Ischemia, Preconditioning, and Preconditioning+Ischemia
In the ipsilesional temporoparietal cortex, SUMO1 protein conjugation significantly increased at 5 and 24 hours after tMCAO at 3, 5, 24, and 72 hours after preconditioning, and at 5 hours after preconditioning+tMCAO ( Figures 1A through 1C) . The results obtained by western blot were confirmed by confocal immunofluorescent experiments. In particular, 5 hours after tMCAO, preconditioning, or preconditioning+tMCAO, SUMO1 immunolabeling increased in the temporoparietal cortex ( Figure 2 ).
SUMO1 Colocalizes With NCX3 in Primary Cortical Neurons in Temporoparietal Cortex and in Striatum of Ischemic or Preconditioned Rats and Immunoprecipitates With NCX3 in Stably Transfected BHK Cells
Immunohistochemical analysis performed on rat brain slices after tMCAO, preconditioning, and preconditioning+tMCAO showed colocalization between NCX3 and SUMO1 signals in the temporoparietal cortex ( Figure 2 and Figure I in the online-only Data Supplement). The colocalization between NCX3 and SUMO1 was further confirmed in primary rat cortical neurons by immunocytochemistry because they colocalized in neuronal cell bodies in primary rat cortical neurons ( Figure 3 ). More important, NCX3 and SUMO1 signals, evaluated by confocal microscopy, colocalized in the same confocal scan. We analyzed the probability of NCX3 sumoylation, by using the SUMO plot analysis program (http://www.abgent.com/sumoplot). This analysis showed that NCX3 contains 9 sequences that might be recognized by the SUMO conjugation enzyme; however, one of these regions was excluded because it is localized extracellularly ( Figure 4A ), according to the newly proposed NCX3 topology. To assess the interaction between SUMO1 and NCX3, we performed immunoprecipitation of lysine 456, a residue with high probability of conjugation, with glutamate (NCX3K456E) did not prevent coimmunoprecipitation between NCX3 and SUMO1 ( Figure 4C ). To restrict the analysis of the putative sumoylation sites, we removed the Ca 2+ binding domain 2, a subregion of the f-loop 528 to 676 (NCX3 F ∆528-676) that contains 3 of the 7 sequences present in the f-loop. This NCX3 deletion mutant showed no immunoprecipitation with SUMO1, thus suggesting that the lysine responsible for sumoylation was present in this region. To determine the single amino acid residue involved in SUMO1 attachment, we performed immunoprecipitation on a site-directed mutant obtained by substituting phenylalanine 589 and lysine 590 with leucine and glutamate, respectively (NCX3FK589LE). In this case as well, no immunoprecipitation was found, thus demonstrating that lysine 590 is required for sumoylation ( Figure 4C ).
The biochemical interaction between SUMO1 and NCX3 was also confirmed in vivo. Indeed, results from immunoprecipitation experiments performed on rat cortex from ischemic and preconditioned animals showed that NCX3 immunoprecipitated with SUMO1 ( Figure 5A) . Intriguingly, NCX1, the other NCX isoform involved in the neuroprotection mediated by preconditioning, 18 did not immunoprecipitate with SUMO1 (data not shown).
SUMO1 Knockdown Downregulates NCX3 Protein Levels After Preconditioning+tMCAO and Reduces the Neuroprotective Effect Elicited by Ischemic Preconditioning in Rats
The effectiveness of siRNAs against SUMO1 was preliminarily evaluated in nonischemic rats ( Figure 6A ). To correlate the neuroprotection mediated by SUMO1 with the interaction between NCX3 and SUMO1, we verified whether SUMO1 knockdown was able to modulate NCX3 expression after tMCAO and after preconditioning+tMCAO. SUMO1 silencing caused a decrease in NCX3 expression 72 hours after tMCAO and after preconditioning+tMCAO in temporoparietal cortex ( Figure 5B) compared with control animals. By contrast, NCX3 expression significantly increased 72 hours after preconditioning+tMCAO in rats receiving siRNA control ( Figure 5B) , as already published. 18 Finally, SUMO1 knockdown induced a significant increase in ischemic volume after tMCAO ( Figures 6B and 6C ) evaluated both 24 and 72 hours after tMCAO induction and, more interestingly, it partially prevented the neuroprotective effect induced by ischemic preconditioning ( Figure 6B ; % infarct volume: 50.9±3 in rats treated with siRNA control and subjected to tMCAO+24 hours reperfusion, 63±1.3 in rats treated with siRNA-A SUMO1 and subjected to tMCAO+24 hours reperfusion, 15.3±1.65 in rats treated with siRNA control and subjected to preconditioning+tMCAO, 39.1±9 in rats treated with siRNA-A SUMO1 and subjected to preconditioning+tMCAO, 44.9±3.4 in rats treated with siRNA control and subjected to tMCAO+72 hours reperfusion, 56.1±2 in rats treated with siRNA-A SUMO1 and subjected to tMCAO+72 hours reperfusion).
Discussion
The results of this study demonstrate that SUMO1 is involved in the neuroprotective mechanisms elicited by in vivo ischemic preconditioning, and more interestingly, propose for the first time NCX3, a downstream key player of neuroprotection in stroke, 17, 18, 30 as a new putative target of SUMO1 neuroprotective action.
Our results showed that silencing of SUMO1 significantly increased the ischemic damage induced in rats by tMCAO and partially reverted the neuroprotection mediated by ischemic preconditioning. Consistent with these data, SUMO1 conjugation pattern significantly increased after ischemia in the ipsilateral temporoparietal cortex, whereas no changes were observed in the striatum (data not shown). The observation that this increase occurred in a brain area that is far less damaged by ischemic injury than the striatum supports the hypothesis that sumoylation constitutes a cell protective response to ischemic injury. More important, our evidence showing that SUMO1 conjugation pattern also increased during ischemic preconditioning in the ipsilateral temporoparietal cortex, where a reduction of the damage occurred, further supports the role of SUMO1 in ischemic preconditioning-induced neuroprotection. The activation of sumoylation elicited by the preconditioning stimulus might be sufficient to generate a long-lasting neuroprotection from the subsequent, 72 hours later, lethal ischemic insult. In fact, the different time intervals for SUMO1 activation between tMCAO and preconditioning+tMCAO may be explained by the fact that sumoylation is a rapidly reversible process, but it may produce a long-lasting effect. 3 Interestingly, confocal analysis revealed that NCX3 and SUMO1 signals increased in the same neurons after preconditioning and preconditioning followed by tMCAO. This finding constituted the prerequisite for a cellular interaction between NCX3 and SUMO1. The results obtained by coimmunoprecipitation experiments demonstrated a direct binding between NCX3 and SUMO1. Lysine 590 might represent the SUMO1 posttranslational modification site on NCX3. Interestingly, this residue is located in the main cytosolic f-loop, a region involved in the regulation of NCX stability and activity, 31, 32 thus suggesting that NCX3 sumoylation might influence the stability of the antiporter. Indeed, an important aspect emerging from this article is that after SUMO1 silencing, a downregulation of NCX3 protein levels occurred during tMCAO and preconditioning+tMCAO, thus indicating that a decrease in SUMO1-mediated protection of NCX3 from degradation may occur. Interestingly, the NCX3 reduction observed after tMCAO alone that we already reported in previous papers 18, 33, 34 was further decreased by SUMO1 silencing 72 hours after the occlusion, thus suggesting that NCX3 sumoylation process also participates in the tMCAO phase. In particular, it reduces NCX3 downregulation, thus contributing to the neuroprotective effect of sumoylation during this phase. More important, whereas NCX3 expression increased after preconditioning+tMCAO when SUMO1 was normally expressed, it decreased to lower levels compared with control conditions after SUMO1 silencing in rats subjected to preconditioning+tMCAO. These results suggest that NCX3 sumoylation by SUMO1 may preserve NCX3 from degradation during ischemic conditions and that NCX3 might be one of the SUMO1-mediated neuroprotective mechanisms involved in ischemic preconditioning.
The involvement of SUMO1 in preconditioning is also supported by previous in vitro observations. For instance, preconditioned neurons maintain elevated SUMO1 conjugation levels, whereas SUMO1-silenced neurons display a reduced survival rate after oxygen and glucose deprivation and an attenuated protective response to preconditioning. 8 Similarly, in in vivo studies, transgenic mice overexpressing SUMO conjugating enzyme, Ubc9, are more resistant to brain ischemia. 35 Interestingly, in the torpor phase of hibernating ground squirrels, 8 which represents a preconditioning-like state, a massive conjugation of SUMO1 occurs that provides a protection to the oligemic conditions.
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Conclusions
Collectively, our results show that SUMO1 plays a fundamental role in the neuroprotection elicited by ischemic preconditioning and that its protective role might be, at least in part, mediated by NCX3 sumoylation. Finally, this posttranslational process may open new experimental studies for generating innovative compounds that could activate sumoylation to enhance the beneficial effect of ischemic preconditioning. META/laser scanning confocal microscope. Single images were taken with an optical thickness of 0.7 m with a size of 1024x1024 pixels from the temporoparietal cortex of control animals not subjected to any surgical procedure and the undamaged contralateral temporoparietal cortex of animals subjected to tMCAO, preconditioning and preconditioning+tMCAO.. In double-labelled sections, the pattern of immunoreactivity for both antigens was identical to that seen in single-stained material. In control groups primary antisera were replaced with normal serum. A possible cross-reactivity between IgGs in double immunolabelling experiments was assessed by processing sections through the same immunocytochemical sequence except that the primary antisera were replaced either with normal serum or with only one primary antibody; the full complement of the secondary antibodies was maintained. In addition, because the secondary antibodies used in this study are highly pre-adsorbed to the IgGs of numerous species, tissue labelling without primary antibodies was also tested to exclude autofluorescence.
ONLINE SUPPLEMENT
No specific staining was observed under these control conditions, thus confirming the specificity of the immunosignals. Confocal microscopic images displaying SUMO1 (green), NCX3 (red), HOECHST (blue), and Merge (yellow) in the temporoparietal cortex of control rats not subjected to any surgical procedure or in contralateral temporoparietal cortex of rats exposed to tMCAO, preconditioning, or preconditioning+tMCAO after 5 hours of reperfusion. A representative brain slice cartoon indicating the area of interest at the top of the Figure. 
